Concepedia

Publication | Open Access

Fear of cancer recurrence therapy (FORT): A randomized controlled trial.

DOIFull Paper Access

32

Citations

0

References

2023

Year

Christine Maheu, Sophie Lebel, Lori J. Bernstein, Christine Courbasson, Mina Singh, Sarah Ferguson, Cheryl Harris, Lynne Jolicoeur, Lorena Baku, Linda Muraca,
Health Psychology

Abstract

This RCT demonstrated that FORT, compared to an attention placebo control group, resulted in a greater reduction in FCR posttreatment and at 3 months posttreatment in women with breast and gynecological cancer, indicating its potential as a new treatment strategy. We recommend a booster session to sustain gains. (PsycInfo Database Record (c) 2023 APA, all rights reserved).